VKVictoria V. Kolodzhieva

Victoria V. Kolodzhieva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Victoria V. Kolodzhieva has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Ornithogenic Ecosystems in the High Arctic as a Source of Virulent Bacteriophages

    by A. E. Goncharov, B. I. Aslanov, D. V. Azarov, V. V. Kolodzhieva, M. V. Gavrilo, А. S. Aksenov, V. M. Shutov, V. T. Shchipletsova, J. M. Polikina, K. A. Mayorova, et al.

    Background. Studying the diversity of bacteriophages in pristine Arctic ecosystems is of significant interest for determining strategies for finding viruses that can be used as antibacterial agents against multidrug-resistant bacteria. The aim of the study was to describe the structure and characteristics of viromes associated with seabird colonies on the Barents Sea islands as a potential source for virulent bacteriophages that can be used for phage therapy of infectious diseases in humans and animals. Material and methods. The study included metagenomic analysis of soil samples collected in the seabird colonies on Severny Island (Novaya Zemlya archipelago) and Western Northbrook Island (Franz-Josef Land archipelago), as well as isolation and sequencing of Escherichia coli bacteriophage genomes from these samples. Metagenomic sequencing was performed on a DNBSEQ-G400 sequencing platform with a paired-end read length of 150 base pairs. Further analysis included assembling raw reads into contigs using MEGAHIT version 1.2.9, followed by classification using Kraken2 and the RefSeq database of viral sequences. Bacteriophage isolation was achieved through the accumulation method using Escherichia coli flora2c and OO17 cultures. The genomes of the two isolated bacteriophages were sequenced, and their phylogenetic relationships were analyzed using the Parsnp program. Results. The structure of metaviromes is dominated by sequences of Caudoviricetes-class tailed phages, accounting for up to 78.45% of the total number of classified viral sequences. The analysis of metavirome data revealed a significant diversity of Caudoviricetes bacteriophages, including Straboviridae and Shitoviridae families and genera such as Baikalvirus and Phitrevirus . Representatives of these genera can be used in phage therapy. Two virulent Escherichia coli bacteriophages were isolated from ornithogenic soil samples. Based on phylogenomic analysis, one of them represents a known species of the genus Justusliebigvirus , while the second can be classified as a novel species of the genus Kagunavirus . Conclusion. The current study reveals a considerable diversity of virulent bacteriophage species in the microbiomes associated with Arctic seabird colonies, suggesting that there is potential for finding new bacteriophages applicable for phage therapy.

  • Open Access

    The Susceptibility of Klebsiella Pneumoniae Strains Isolated from COVID-19 Patients to Commercially Available Bacteriophage Medications

    by B. I. Aslanov, A. E. Goncharov, S. D. Konev, A. S. Mochov, D. A. Azarov, E. А. Lebedeva, A. V. Kuleshova, V. V. Kolodzhieva, E. N. Kolosovskaya, A. M. Nifontova, et al.

    Background. Superinfection caused by Klebsiella pneumoniae occupies a leading position in the structure of bacterial complications in COVID-19 patients. The intensive circulation of Klebsiella in specialised hospitals has contributed to the consolidation of the most clinically and epidemiologically important strains of this pathogen, in particular, representatives of hypervirulent and carbapenem-resistant clonal lines, which have not lost their relevance even in the post-pandemic period. The use of bacteriophages as therapeutic and anti-epidemic agents seems justified given the widespread use of multidrugresistant strains of K. pneumoniae.Aim of the study. To evaluate the susceptibility of K. pneumoniae strains associated with nosocomial infections in patients with COVID-19 to polyvalent bacteriophage medications.Materials and methods. The study included 96 non-repeating K. pneumoniae strains isolated from clinical material of patients admitted to a major hospital in St. Petersburg with severe and moderate forms of COVID-19 from May 2020 to January 2021. The susceptibility of clinical strains to bacteriophages was assessed using the spot test analysis. Commercially available bacteriophage preparations used for testing included the following: purified polyvalent pyobacteriophage, sextaphage, and purified polyvalent Klebsiella pyobacteriophage. In order to identify the probable mechanisms of resistance of hospital strains of K. pneumoniae, the nucleotide sequences of the genomes of 6 strains of this pathogen belonging to the dominant hospital genetic lines ST3, ST39, ST307, ST395, ST874 were studied.Results. Negative results of spot tests were observed in 32.29% (95% CI=23.8–42.2) of cases; in general, the proportion of patients eligible for treatment with phage therapy was 49% (95% CI=39.2–58.8). Loci of class 1 subtypes IV-A3 and I-E, potentially associated with resistance to CRISPR-Cas, were identified in the genome structure of the studied strains, as well as a number of prophage sequences potentially associated with resistance to bacteriophages.Conclusion. The study demonstrated low activity of polyvalent bacteriophage medications against K. pneumoniae strains causing nosocomial infections in patients with COVID-19. Increasing the diversity of bacteriophage strains active against epidemiologically relevant K. pneumoniae clones can expand the possibilities of phage therapy for Klebsiella infections. The rational use of medications containing these bacteriophages is possible within the paradigm of personalised phage therapy.


  • Open Access

    Pathogenic potential of ornithogenic Escherichia coli strains detected in the Earth's polar regions

    by Batyrbek I. Aslanov, Daniil V. Azarov, Maria A. Makarova, Elizaveta G. Marysheva, Lyudmila A. Kraeva, Aleksey S. Mokhov, Ekaterina A. Lebedeva, Nikita E. Goncharov, Natalya V. Lebedeva, Dmitry A. Starikov, et al.

    Introduction. Pathogenic strains of Escherichia coli are an important object of surveillance within the One Health concept in the wild, agriculture and human society. Migratory bird colonies and high latitude avian colonies may be points of active intraspecies and interspecies contact between different animal species, accompanied by the spread of pathogens. At the same time, the phylogeography of E. coli in relation to the presence of natural foci of colibacillosis in polar regions remains virtually unstudied. The aim of this study was to assess the pathogenic potential of E. coli strains from the polar regions of the Earth, based on the analysis of the genomes of these bacteria from typical ornithogenic ecosystems of the Arctic and Antarctic. Materials and methods. The study used collections of E. coli isolated from ornithogenic biological material during expeditions to high latitude areas of the Arctic (archipelagos of Novaya Zemlya, Franz Josef Land, Svalbard) and Antarctic (Haswell Archipelago). 16 cultures associated with avian E. coli (12 polar and 4 temperate strains) were selected for genome-wide sequencing using BGI technology. The annotation of the genomes focused on the identification of genes for pathogenicity factors and antimicrobial resistance, as well as the identification of strains belonging to individual genetic lineages using the cgMLST method. Results. The annotation of the genomes allowed their assignment to different sequence types in the multilocus sequencing typing and genome-wide sequencing typing schemes. The analysis of the geographical distribution of the sequence types of polar E. coli strains determined by the cgMLST method showed their global representation in geographically distant regions of the planet. For example, cgST 133718 was observed in Antarctica (strain 17_1myr) and in the UK, and sequence 11903, to which strain 32-1 from the northernmost point of Novaya Zemlya belonged, was previously identified in the USA. All strains studied were characterized by the presence of extensive virulence. Among the pathogenicity factors identified were haemolysins A, E, F, siderophores, including the yersiniabactin gene cluster, a number of adhesion, colonization and invasion factors, as well as the thermostable enterotoxin EAST-1 and genes that characterize enteroaggregative strains of E. coli (the virulence regulator gene eilA and enteroaggregative protein (air)). One of the Arctic strains (33-1) had determinants of antibiotic resistance, in particular the extended-spectrum beta-lactamase gene TEM-1b and the Tn1721 transposon, including tetracycline resistance genes (tetA-TetR), were detected in its genome. Conclusion. The results of the study indicate the circulation of E. coli strains with strong pathogenic potential in high-latitude Arctic and Antarctic ornithogenic ecosystems. The analysis of genomic data indicates the presence of geographically widespread genetic lineages in these regions, which justifies the importance of monitoring epidemic clones of E. coli, along with monitoring for other pathogens, in bird colonies in high-latitude areas.


  • Open Access

    First Finding of the Emerging Pathogen Escherichia marmotae in the Arctic

    by B. I. Aslanov, A. E. Goncharov, V. V. Kolodzhieva, D. V. Azarov

    Relevance. Escherichia marmotae is a recently described species of Escherichia that is considered a potential new zoonotic pathogen. The geographical distribution of this microorganism in wild animals and its genomic diversity are currently insufficiently studied. Aims. The purpose of the study was to determine the pathogenic potential of the Escherichia marmotae 16guk strain isolated from zoogenic material on Hooker Island (Arkhangelsk Region, Franz Josef Land Archipelago) and its phylogenetic relationships with previously described strains of different origin. Materials and methods. The Escherichia marmotae 16guk strain was isolated from the faeces of an arctic fox (Vulpes lagopus) near a breeding ground. The pathogenic potential of the strain was assessed on the basis of genomic sequencing data using Illumina technology, an estimate of the mean lethal dose when administered intraperitoneally to mice, and an assessment of the antibiotic resistance phenotype using the disc diffusion method. To determine the phylogenetic position of the described strain within the overall structure of the microbial population, genome-wide sequencing data deposited in NCBI GeneBank were used. The phylogenomic analysis was performed based on the distance matrix of single nucleotide polymorphisms in the core genome due Parsnp. Results. The strain is characterized by low virulence when tested on mice (LD50 was 1.3*109 K.O.E.), has resistance to ampicillin and gentamicin. A number of pathogenicity factors have been identified in the genome structure, which includes siderophores of enterobactin and aerobactin operons, fimbria type I genes characteristic of extraintestinal Escherichia strains, amyloid-like protein villi (curli) and capsular genes, as well as the ibeABC invasion factor operon. The resistome is represented by blaEC15 beta-lactamase genes and acrAD-TolC efflux pump genes. According to the results of phylogenomic analysis, the strain under study shows the greatest similarity with the genome sequences of strains circulating in New Zealand and Germany among wild animals (wild boars) and birds. The similarity of the genomes of strains distributed in distant geographical regions and the isolation of the 16guk strain within an ornithogenic ecosystem can be interpreted as a result of the spread of E. marmotae with migratory birds. Conclusions. The discovery of the Escherichia marmotae 16guk strain in one of the most remote Arctic territories demonstrates the possibility of the emergence and circulation of enterobacteria strains with significant pathogenic potential in the island territories of the high-latitude Arctic, which actualizes the need for systematic monitoring studies in this region.


  • Open Access

    Comprehensive Assessment of Risk Factors for Colon Cancer in the Population of the North-West of Russia

    by V. N. Shumilova, A. E. Goncharov, E. L. Latariya, R. E. Topuzov, M. A. Bobrakov, V. V. Kolodzhieva, Т. С. Филь, B. I. Aslanov

    Relevance. Colorectal cancer (CRC) is the third most common cancer in the world. In the Russian Federation, high rates of neglect in late diagnosis of colon cancer have been established. The study of the complex influence of social, clinical, anamnestic and dietary risk factors in the development of colorectal cancer is valuable in identifying risk groups for effective secondary prevention. Aims. Assessment of the importance of medical and social, clinical and anamnestic, alimentary-dependent factors as risk factors for colon cancer. Materials & Methods. To analyse the regional characteristics of CRC incidence, the database "Cancer diseases in the Northwestern Federal District" for 2010-2023 was used. To investigate the risk factors for CRC, a case- control study was organised in which patients over 18 years of age with or without diagnosed intestinal pathology (colorectal cancer, inflammatory bowel disease) were included. Results and discussion. Among patients with CRC, patients with advanced forms of the disease predominated: the proportion of CRC diagnosed at stage III and IV was 54% and 17% of newly diagnosed cases, respectively. When analyzing the data, no association was found between the risk of developing CRC and the presence of chronic diseases, oncological pathology, including CRC in relatives of the 1st and 2nd degree of kinship, alcohol abuse and smoking, as well as with most alimentary-dependent factors, with the exception of fried and smoked fish. Conclusions. Colon neoplasms are detected in the population of the Northwestern Federal District at late stages and when patients seek medical care independently. Significant attention in epidemiological studies should be paid to such a factor as eating fish after certain types of heat treatment (fried and smoked). prospects for further research, in our opinion, are related to the search for informative markers to identify risk groups, in particular factors associated with altered intestinal microbiota and colonisation of the intestine with potentially oncogenic microorganisms.

  • Open Access

    Characteristics of Genomes of Opportunistic Bacteria in Zoogenic Ecosystems of the Russian Western Arctic Islands

    by Batyrbek I. Aslanov, Artemiy E. Goncharov, Daniil V. Azarov, Anna N. Trofimova, Andrey S. Aksenov, Ivan A. Mizin, Viktoria V. Kolodzhieva, Daria A. Kushnirenko, Lyudmila A. Kraeva, Alexander L. Panin, et al.

    Introduction: Arctic ecosystems are the most important object of microbiological surveillance that helps monitor a rapidly changing natural environment affected by climate change and industrial development of the northern territories. Objective: To assess the epidemic potential of opportunistic bacteria associated with animals from the Arctic islands of the Barents and Kara Seas. Materials and methods: We have studied four strains of gram-negative opportunistic bacteria (Serratia fonticola, Aeromonas salmonicida, Yersinia kristensenii, and Yersinia rochesterensis) isolated in 2021–2022 during microbiological testing of 46 samples of zoogenic biologic materials from the natural ecosystems of Vaigach Island, Novaya Zemlya and Franz Josef Land archipelagos. Genomes of the isolated microbial strains were sequenced using the Illumina MiSeq sequencing system and, after de novo assembly using the SPAdes 13.0 genomic assembler, annotated with RAST (Rapid Annotation using Subsystem Technology). Results: The strains were shown to possess a number of virulence factors and antibiotic resistance genes, which allows them to be considered as potential pathogens. Classes A, B, and C beta-lactamases were found in the genomes of all the bacteria under study, and operons for siderophores and type IV secretion systems were typical of virulence factors. In addition, the pertussis-like YtxA enterotoxin was identified in Yersinia genomes. Conclusions: Our findings indicate the possibility of emergence of natural foci of notifiable infections on the islands in the high-latitude Arctic promising in terms of tourism development and economic growth.


  • Open Access

    The effect of Locally Applied Bacillus safensis Strain 440-1 from Antarctic Soil on the Course of Experimental Wound Staphylococcal Infection

    by B. I. Aslanov, V. V. Kolodzhieva, E. A. Lebedeva, I. A. Tumanyan, Yu. D. Won, A. S. Mokhov, A. A. Dolgiy, A. E. Goncharov, Ю. Д. Вон

    Relevance. Infections caused by methicillin-resistant strains of Staphylococcus aureus are an urgent problem of hospital epidemiology, and control measures involve the development of new antimicrobials. Probiotics based on bacterial strains isolated fro natural habitats are considered promising means of combating MRSA.Aims. To test the possibility of using the Bacillus safensis 440-1 strain isolated from Antarctic soil. as an antibacterial agent for the treatment of experimental staphylococcal infection.Purpose of the study – check the possibility of using the Bacillus safensis 440-1 strain, isolated from Antarctic soil, as a topical antibacterial agent for the treatment of experimental staphylococcal infection.Material and methods. The potential virulence of Bacillus safensis strain 440-1 was studied on a mouse peritonitis model, and its activity against the methicillin-resistant Staphylococcus aureus SA776 test strain was studied on a localized wound infection model.Results and discussion. Our study demonstrated the safety of the tested strain due intraperitoneal use. We found that the use of the studied strain reduces the staphylococci amount in wounds from the third day from the start of the study to the end of the observation period, without aggravating the course of the infection.Conclusion. Bacillus safensis strain is a promising potential probiotic and it can be used as a part of complex antiseptic or disinfectant after additional studies aimed at developing an optimal mode of its use.

  • BIOPROSPECTING OF POTENTIAL PRODUCERS OF NEW ANTIMICROBIAL COMPOUNDS IN TERRESTRIAL ECOSYSTEMS OF ANTARCTICA

    by B.I. Aslanov, A.E. Goncharov, D.V. Azarov, E.A. Lebedeva, K.V. Gusarova, A.P. Solomenny, V.V. Kolodzhieva

    Экстремально холодные биогеоценозы Арктики и Антарктики рассматриваются в качестве наиболее перспективных источников новых антимикробных соединений.Цель исследования заключалась в идентификации штаммов бактерий - потенциальных продуцентов антимикробных соединений в наземных экосистемах антарктических оазисов.Материалы и методы. Антагонистическую активность коллекции из 98 антарктических мезофильных бактерий проверяли методом двухслойного агара с использованием в качестве индикаторных эпидемических штаммов MRSA, мультиантибиотикорезистентных штаммы Eschericia coli, эритромицин-устойчивых штаммов Streptococcus pyogenes и Streptococcus agalactiae. Проведено геномное секвенирование штамма Bacillus safensis 440-1 c целью детекции генов антимикробных пептидов.Результаты и обсуждение. Выявлено 10 штаммов антарктических бактерий - антагонистов условно-патогенных и патогенных бактерий. Геном штамма Bacillus safensis 440-1, проявившего выраженную антагонистическую активность по отношению к индикаторным культурам, содержит гены антимикробных пептидов (плантозолицин - подобного фактора, пумиларин - подобного белка, лантибиотик-подобного белка), и не содержит генов факторов патогенности. Сделан вывод о том, что антарктический штамм Bacillus safensis 440-1 имеет перспективы практического применения в качестве продуцента антимикробных пептидов или пробиотика.Заключение. Биопроспектинг продуцентов антимикробных препаратов в природных экосистемах полярных регионов планеты является эффективной стратегией поиска альтернатив классическим антибиотикам, при этом существенное внимание должно быть уделено представителям рода...


  • FEATURES OF THE MICROBIOME STRUCTURE OF THE UPPER RESPIRATORY TRACT OF OUTPATIENT AND IPATIENTS WITH A NEW CORONAVIRUS INFECTION

    by A.S. Mokhov, D.V. Azarov, V.V. Kolodzhieva, K.D. Vasiliev, E.A. Lebedeva, E.R. Tsoy, V.V. Gostev, A.E. Goncharov, A.V. Romanov, B.I. Aslanov

    В настоящее время относительно слабо изучена роль изменений структуры нормальной микробиоты респираторного тракта в качестве фактора риска осложнений новой коронавирусной инфекцией. В связи с этим исследования в данной области остаются актуальными.Цель. Провести сравнительный анализ структуры микробиома глотки у госпитализированных пациентов с новой коронавирусной инфекцией и пациентов, состояние которых не потребовало госпитализации, на основе таргетного метагеномного секвенирования гена 16S rRNA.Материал и методы. B исследование вошли пациенты с подтверждённым диагнозом новая коронавирусная инфекция, обратившиеся за помощью в медицинские организации в октябре-декабре 2020 г. Изучение особенностей микробиоты глотки, ассоциируемых с риском госпитализации, было выполнено с использованием дизайна «случай контроль». В группу «случаев» вошли 18 пациентов, которые были госпитализированы в специализированный стационар. Данные пациенты были обследованы дважды: в течение первых суток госпитализации и на 6-12-й день госпитализации).Контрольная группа включила 18 пациентов, которые в ходе амбулаторного лечения не были госпитализированы. Результаты. В результате проведенных исследований установлено, что риск госпитализации ассоциирован с отсутствием в структуре микробиоты глотки Akkermansia spp., Sneathia spp. и снижением удельного веса лактобацилл, атакже с более частым выявлением у госпитализированных пациентов Megasphaera spp.Заключение. Полученные данные обосновывают необходимость применения молекулярно-генетических методов, направленных на качественное и количественное определение перечисленных микроорганизмов при определении групп риска госпитализации и тяжелого течения новой коронавирусной...


  • Open Access

    Spread of Multi-Antibiotic-Resistant Health-Care Pathogens in Hospitals to Treat COVID-19 Patients

    by A. E. Goncharov, L. P. Zueva, A. S. Mokhov, V. V. Kolodzhieva, A. A. Meltser, M. V. Smirnova, T. V. Khavlina, E. A. Orishak

    Relevance. The COVID-19 pandemic has led to significant overloads in the work of health systems in many countries, a shortage of beds and staff, which contributes to a decrease in adherence to measures to prevent and control nosocomial infections, which can significantly worsen the course of viral pneumonia. Aim. To assess the possibility of the formation of hospital strains of multidrugresistant microorganisms in hospitals repurposed to provide medical care to patients with COVID-19. Materials and methods. The study included patients with severe and moderate forms of COVID-19 (ICD codes U07.1, U07.2), who were admitted to two large hospitals repurposed for the treatment of this infection. The data of microbiological studies of the biomaterial associated with the respiratory tract (sputum, bronchoalveolar lavage, tracheal aspirates) obtained from 1101 patients from May to January 2021 were analyzed using a combination of molecular genetic methods (RAPD-PCR, detection of integrons and the carbapenemase gene bla NDM.), and molecular typing of carbapenem-resistant strains of Klebsiella pneumoniae and Acinetobacter baumannii was carried out. Results. It was found that carbapenem resistant gram-negative bacteria predominate in the structure of the nosocomial microbiota of the respiratory tract of patients with COVID-19 in both hospitals. Based on molecular typing made the wide distribution of several genetic lines of integron-positive carbapenem resistant Klebsiella pneumoniae and Acinetobacter baumannii was detected. Conclusions. The COVID-19 pandemic has exacerbated the spread and circulation of bacteria with multiple antibiotic resistance in hospitals. This study has demonstrated the possibility of the formation of hospital strains of nosocomial infections in COVID-19 hospitals, which justifies the need to improve infection control measures in the context of a new coronavirus infection pandemic.